USFDA recognizes Natco Pharma’s Kothur Formulation Facility as acceptable

18 Sep 2014 Evaluate

Natco Pharma’s Kothur Formulation facility has been found acceptable by United States Food and Drug Administrator (USFDA). The company has received a letter dated July 14, 2014 after completing review of the Establishment Inspection Report (EIR) for the inspection conducted from May 19 to 23, 2014. The facility was classified as acceptable.

The company has made proposed commitments and corrective actions based on the minor and routine observations during inspection. It continues to manufacture and sell products in the US.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

895.90 -12.20 (-1.34%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×